| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 178.256 | 82 |
| GSM780708 | Untreated after 4 days (C2_1) | 146.391 | 80 |
| GSM780709 | Untreated after 4 days (C3_1) | 158.977 | 81 |
| GSM780719 | Untreated after 4 days (C1_2) | 165.084 | 82 |
| GSM780720 | Untreated after 4 days (C2_2) | 137.356 | 79 |
| GSM780721 | Untreated after 4 days (C3_2) | 181.65 | 83 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 172.285 | 82 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 156.52 | 81 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 136.73 | 79 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 145.517 | 80 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 158.185 | 81 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 137.237 | 79 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 165.545 | 82 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 158.826 | 81 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 173.649 | 82 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 140.866 | 80 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 159.19 | 81 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 164.429 | 81 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 139.241 | 80 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 166.553 | 82 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 164.953 | 81 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 140.009 | 80 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 161.994 | 81 |